Similar companies
Astrazeneca Monthly Web Traffic
Astrazeneca’s website receives an estimated 924,000 monthly visits, down 20.4% over the past three months. Declining web traffic can signal weakening consumer demand and can be an early indicator of revenue deceleration.
At 924,000 monthly visits, Astrazeneca trails industry peers like Johnson & Johnson (2.3 million) and Eli Lilly and Company (8.8 million).
How Web Traffic Impacts AZN’s AI Score
Web traffic is a real-time read on consumer demand and brand engagement: for consumer-facing companies, a sustained change in website visits can precede changes in reported revenue. AltIndex feeds Astrazeneca’s monthly visit estimates into the AZN AI Score as one of 25+ alternative data signals, where traffic momentum is weighed against hiring, sentiment, and fundamentals.
For other growth metrics, see Astrazeneca app downloads, Google Trends, Instagram followers, and LinkedIn headcount.
Month over Month
| Jun 2026 | 924,000 | |
| May 2026 | 924,000 | |
| Apr 2026 | 948,000 | |
| Mar 2026 | 1,161,000 | |
| Feb 2026 | 1,061,000 | |
| Jan 2026 | 1,138,000 |
Astrazeneca Web Traffic: Frequently Asked Questions
Astrazeneca's website receives approximately 924,000 monthly visits, based on AltIndex's estimate aggregated from the top web traffic data providers. This figure includes desktop and mobile visitors to the company's primary domain.
Astrazeneca's web traffic is down 20.4% over the past three months. This is a significant change that may indicate shifting consumer interest.
Web traffic is a real-time indicator of consumer demand and brand engagement. For consumer-facing companies, declining website visits can precede revenue slowdowns. AltIndex tracks web traffic as one of 25+ signals in its AI Score model.
No single data point predicts a stock price on its own, but website traffic is a leading indicator: a sustained shift in Astrazeneca's monthly visitors can show up before it reaches reported revenue. That is why AltIndex combines AZN's web traffic trend with hiring, sentiment, app downloads, and 20+ other signals in its AI Score rather than reading any one signal in isolation.
Astrazeneca underperforms its industry peers when it comes to Webpage traffic, ranking in the 10th percentile.
Sign up and get more insights on Astrazeneca and its Webpage performance.
See Astrazeneca’s complete webpage traffic history
Sign up to unlock 1-year and all-time charts for AZN — plus 25+ alternative data signals, AI Scores, and real-time alerts.
Sign up
